Editorial: Benefits and risks of agonist triggering strategies.
作者信息
Tesarik Jan
机构信息
MARGen Clinic, Granada, Spain.
出版信息
Front Endocrinol (Lausanne). 2024 Dec 23;15:1538412. doi: 10.3389/fendo.2024.1538412. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Benefits and risks of agonist triggering strategies.社论：激动剂触发策略的益处与风险
Front Endocrinol (Lausanne). 2024 Dec 23;15:1538412. doi: 10.3389/fendo.2024.1538412. eCollection 2024.
2
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素（GnRH）拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险：一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
3
The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.促性腺激素释放激素激动剂扳机方案可提高新鲜胚胎移植周期的活产率，但不能提高正常反应者的累积活产率：一项随机对照试验及分子机制研究。
Hum Reprod. 2020 Jun 1;35(6):1306-1318. doi: 10.1093/humrep/deaa086.
4
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.促性腺激素释放激素激动剂用于在促性腺激素释放激素拮抗剂卵巢过度刺激方案中触发最终卵母细胞成熟：一项系统评价和荟萃分析。
Hum Reprod Update. 2006 Mar-Apr;12(2):159-68. doi: 10.1093/humupd/dmi045. Epub 2005 Oct 27.
5
[Comparative Study of the Embryo Development and Clinical Outcomes of 3 Ovarian Stimulation Protocols in Different Age Groups].[不同年龄组3种卵巢刺激方案的胚胎发育及临床结局的比较研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):580-587. doi: 10.12182/20240560508.
6
GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation.在控制性卵巢刺激中，对于卵巢反应正常的患者，使用 GnRH 拮抗剂与卵泡期单次剂量 GnRH 激动剂方案的比较。
Gynecol Endocrinol. 2019 Apr;35(4):309-313. doi: 10.1080/09513590.2018.1528221. Epub 2018 Nov 15.
7
Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.子宫内膜异位症相关性不孕女性控制性卵巢刺激后的妊娠结局：促性腺激素释放激素激动剂与促性腺激素释放激素拮抗剂的比较
J Gynecol Obstet Hum Reprod. 2017 Nov;46(9):681-686. doi: 10.1016/j.jogoh.2017.09.007. Epub 2017 Sep 29.
8
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.促性腺激素释放激素激动剂扳机后改良黄体支持在高风险患者中可获得一致的高临床妊娠率和低卵巢过度刺激综合征率：一项回顾性多中心研究。
Hum Reprod. 2013 Sep;28(9):2529-36. doi: 10.1093/humrep/det304. Epub 2013 Jul 19.
9
Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation.在促性腺激素释放激素拮抗剂/促性腺激素释放激素激动剂、促性腺激素释放激素拮抗剂/人绒毛膜促性腺激素或长效方案卵巢刺激后进行冷冻胚胎移植的结果相似。
Reprod Biomed Online. 2007 Feb;14(2):148-54. doi: 10.1016/s1472-6483(10)60781-x.
本文引用的文献
1
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.体外受精/卵胞浆内单精子注射周期中促性腺激素释放激素拮抗剂方案里促性腺激素释放激素激动剂扳机与绒毛膜促性腺激素扳机的比较：一篇综述文章
Int J Reprod Biomed. 2016 Sep;14(9):557-566.
2
Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.在控制性卵巢刺激周期的辅助生殖过程中，对同一批患者使用促性腺激素释放激素激动剂方案和拮抗剂方案的比较。
Int J Clin Exp Pathol. 2013 Aug 15;6(9):1903-10. eCollection 2013.
3
GnRH in pregnancy.孕期促性腺激素释放激素
Arch Gynecol Obstet. 1996;259(1):1-6. doi: 10.1007/BF02505301.
Zotero 插件